Related Experiment Video
Updated: Jul 18, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Fibrogenesis in Crohn's disease
John P Burke1, Jurgen J Mulsow, Conor O'Keane
1Department of Surgery, Mater Misericordiae University Hospital and UCD School of Medicine and Medical Sciences, Dublin, Ireland.
The American Journal of Gastroenterology
|December 13, 2006
Summary
Fibrostenosis in Crohn's disease (CD) involves complex interactions leading to bowel strictures. Targeting transforming growth factor-beta (TGF-β) pathways may offer new therapeutic strategies for stricturing CD.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease
- Fibrosis Research
Background:
- Crohn's disease (CD) frequently leads to intestinal strictures, necessitating surgery in most patients.
- While CD inflammation is well-studied, the pathogenesis of strictures remains poorly understood.
- Fibrogenesis, the process of scar tissue formation, is a key factor in stricture development.
Purpose of the Study:
- To review the current understanding of fibrogenesis in Crohn's disease.
- To outline potential research directions and therapeutic strategies for CD-associated fibrosis.
Main Methods:
- Comprehensive literature review of CD-associated fibrosis from January 1966 to May 2006.
- Cross-referencing of key articles to identify relevant studies.
Main Results:
- CD fibrosis stems from chronic inflammation and interactions between mesenchymal cells, cytokines, and inflammatory cells.
- Fibroblasts are central to stricture formation, altering bowel wall structure and collagen deposition.
- Transforming growth factor-beta (TGF-β) is critical, promoting extracellular matrix production and dysregulated turnover.
Conclusions:
- Enhanced understanding of fibrostenosis biology can significantly improve care for stricturing CD.
- Novel therapeutic targets and biomarkers for prognostication and monitoring are potential outcomes.
- Modulating TGF-β downstream targets represents a promising therapeutic avenue.
More Related Videos
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...